SRL
INDV icon

Scientech Research LLC’s Indivior Pharmaceuticals INDV Stock Holding History

Scientech Research LLC’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,201
Closed -$311K – 393
2026
Q1 		$311K Buy
10,201
+3,166
+45% +$105K 0.26% 116
2025
Q4 		$252K Buy
+7,035
New +$215K 0.16% 245

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Scientech Research LLC's INDV Position: Q2 2026 in Review

Scientech Research LLC sold out of Indivior Pharmaceuticals (INDV) in Q2 2026, closing a stake of 10,201 shares — an estimated $311K sold.

Scientech Research LLC first reported a position in INDV in Q4 2025 and held it in 2 quarters. The position peaked at $311K in Q1 2026. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Scientech Research LLC reported no remaining Indivior Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 10,201 Indivior Pharmaceuticals shares in Q2 2026, an estimated $311K.
  • Scientech Research LLC first reported a position in Indivior Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Scientech Research LLC's Indivior Pharmaceuticals position peaked at $311K in Q1 2026.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.